Concentra Group Holdings Parent, Inc. (CON) is a Medical - Equipment & Services company in the Healthcare sector, currently trading at $22.75. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CON = $36.80 (+61.8% from the current price, the stock appears undervalued). Analyst consensus target is CON = $42 (+82.4% upside).
Valuation: CON trades at a trailing Price-to-Earnings (P/E) of 16.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.18.
Financials: revenue is $2.2B, +7.9%/yr average growth. Net income is $173M, growing at +1.4%/yr. Net profit margin is 8% (thin). Gross margin is 28.3% (+4.6 pp trend).
Balance sheet: total debt is $2.1B against $393M equity (Debt-to-Equity (D/E) ratio 5.35, leveraged). Current ratio is 1.14 (adequate). Debt-to-assets is 69.2%. Total assets: $3.0B.
Analyst outlook: 4 / 4 analysts rate CON as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 76/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 53/100 (Partial), Future 100/100 (Pass), Income 45/100 (Partial).
